Joey Orpilla

2.2k total citations
11 papers, 500 citations indexed

About

Joey Orpilla is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Joey Orpilla has authored 11 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Immunology and 5 papers in Genetics. Recurrent topics in Joey Orpilla's work include Immunotherapy and Immune Responses (7 papers), Glioma Diagnosis and Treatment (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Joey Orpilla is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Glioma Diagnosis and Treatment (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Joey Orpilla collaborates with scholars based in United States, Italy and United Kingdom. Joey Orpilla's co-authors include Richard G. Everson, Timothy F. Cloughesy, Linda M. Liau, Robert M. Prins, Horacio Soto, Diana Moughon, Joseph Antonios, Shaina Sedighim, William H. Yong and Jenny C. Kienzler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Neurosurgery.

In The Last Decade

Joey Orpilla

10 papers receiving 497 citations

Peers

Joey Orpilla
Leonel Ampie United States
Caitlin Creasy United States
Brian M. Andersen United States
Irina Fernandez United States
Yuxia Meng France
Amy Saur Conway United States
Kira Downey United States
Leonel Ampie United States
Joey Orpilla
Citations per year, relative to Joey Orpilla Joey Orpilla (= 1×) peers Leonel Ampie

Countries citing papers authored by Joey Orpilla

Since Specialization
Citations

This map shows the geographic impact of Joey Orpilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joey Orpilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joey Orpilla more than expected).

Fields of papers citing papers by Joey Orpilla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joey Orpilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joey Orpilla. The network helps show where Joey Orpilla may publish in the future.

Co-authorship network of co-authors of Joey Orpilla

This figure shows the co-authorship network connecting the top 25 collaborators of Joey Orpilla. A scholar is included among the top collaborators of Joey Orpilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joey Orpilla. Joey Orpilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Sanvito, Francesco, Catalina Raymond, Nicholas S. Cho, et al.. (2023). Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRI. European Radiology. 34(5). 3087–3101. 7 indexed citations
2.
Sun, Matthew Z., Joey Orpilla, Janet Treger, et al.. (2022). EXTH-87. DECITABINE POTENTIATES MENINGIOMA IMMUNOTHERAPY TARGETING NY-ESO-1. Neuro-Oncology. 24(Supplement_7). vii229–vii229.
3.
Lee, Alex, Lu Sun, Aaron Mochizuki, et al.. (2021). Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma. Nature Communications. 12(1). 6938–6938. 135 indexed citations
4.
Peeters, Sophie, Geoffrey C. Owens, Matthew Z. Sun, et al.. (2020). Dendritic Cell Vaccination is Effective Against H3.3G34R Mutant Glioblastoma in a Novel Syngeneic Genetically Engineered Mouse Model. Neurosurgery. 67(Supplement_1). 1 indexed citations
5.
Prins, Robert M., Aaron Mochizuki, Joey Orpilla, et al.. (2018). ATIM-12. NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY PROMOTES INTRATUMORAL AND SYSTEMIC IMMUNE RESPONSES IN RECURRENT GLIOBLASTOMA: AN IVY CONSORTIUM TRIAL. Neuro-Oncology. 20(suppl_6). vi3–vi3. 1 indexed citations
6.
Orpilla, Joey, Aaron Mochizuki, Neha Akkad, et al.. (2018). ATIM-25. NEOADJUVANT PD-1 ANTIBODY BLOCKADE IS ASSOCIATED WITH FOCAL UPREGULATION OF PD-L1 AND CD8 T CELL INFILTRATE IN RECURRENT GLIOBLASTOMA. Neuro-Oncology. 20(suppl_6). vi6–vi6. 2 indexed citations
7.
Antonios, Joseph, Horacio Soto, Richard G. Everson, et al.. (2017). Detection of immune responses after immunotherapy in glioblastoma using PET and MRI. Proceedings of the National Academy of Sciences. 114(38). 10220–10225. 69 indexed citations
8.
Antonios, Joseph, Horacio Soto, Richard G. Everson, et al.. (2016). Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma. Neuro-Oncology. 19(6). now287–now287. 151 indexed citations
9.
Antonios, Joseph, Horacio Soto, Richard G. Everson, et al.. (2016). PD-1 blockade enhances the vaccination-induced immune response in glioma. JCI Insight. 1(10). 125 indexed citations
10.
Moughon, Diana, Richard G. Everson, Sylvia K. Odesa, et al.. (2016). ATIM-32. PHASE IIA CLINICAL TRIAL EVALUATING DENDRITIC CELL VACCINE FOR THE TREATMENT OF LOW-GRADE GLIOMAS. Neuro-Oncology. 18(suppl_6). vi25–vi25. 1 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026